vs

Side-by-side financial comparison of PATHWARD FINANCIAL, INC. (CASH) and Immunocore Holdings plc (IMCR). Click either name above to swap in a different company.

PATHWARD FINANCIAL, INC. is the larger business by last-quarter revenue ($173.1M vs $104.5M, roughly 1.7× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs -0.2%). PATHWARD FINANCIAL, INC. produced more free cash flow last quarter ($104.1M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs -18.0%).

Pathward Financial, Inc. is a U.S.-based banking and financial services company. It adopted its current name in 2022 after its parent, Meta Financial Group, sold the "Meta" trademark to Meta Platforms.

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

CASH vs IMCR — Head-to-Head

Bigger by revenue
CASH
CASH
1.7× larger
CASH
$173.1M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+24.5% gap
IMCR
24.3%
-0.2%
CASH
More free cash flow
CASH
CASH
$139.6M more FCF
CASH
$104.1M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
-18.0%
CASH

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CASH
CASH
IMCR
IMCR
Revenue
$173.1M
$104.5M
Net Profit
$35.2M
Gross Margin
97.4%
Operating Margin
24.6%
-18.8%
Net Margin
20.3%
Revenue YoY
-0.2%
24.3%
Net Profit YoY
11.9%
EPS (diluted)
$1.57
$-0.61

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CASH
CASH
IMCR
IMCR
Q4 25
$173.1M
$104.5M
Q3 25
$186.7M
$103.7M
Q2 25
$195.8M
$98.0M
Q1 25
$274.8M
$93.9M
Q4 24
$182.6M
$84.1M
Q3 24
$179.5M
$80.2M
Q2 24
$188.6M
$75.4M
Q1 24
$257.6M
$70.5M
Net Profit
CASH
CASH
IMCR
IMCR
Q4 25
$35.2M
Q3 25
$38.8M
$-177.0K
Q2 25
$42.1M
$-10.3M
Q1 25
$75.0M
$5.0M
Q4 24
$30.0M
Q3 24
$33.5M
$8.7M
Q2 24
$44.9M
$-11.6M
Q1 24
$69.9M
$-24.4M
Gross Margin
CASH
CASH
IMCR
IMCR
Q4 25
97.4%
Q3 25
99.5%
Q2 25
98.9%
Q1 25
99.1%
Q4 24
99.6%
Q3 24
99.4%
Q2 24
97.7%
Q1 24
99.7%
Operating Margin
CASH
CASH
IMCR
IMCR
Q4 25
24.6%
-18.8%
Q3 25
25.9%
-6.9%
Q2 25
24.1%
-15.2%
Q1 25
33.2%
-3.9%
Q4 24
19.8%
-23.1%
Q3 24
20.9%
-10.6%
Q2 24
27.1%
-21.2%
Q1 24
33.8%
-37.6%
Net Margin
CASH
CASH
IMCR
IMCR
Q4 25
20.3%
Q3 25
20.8%
-0.2%
Q2 25
21.5%
-10.5%
Q1 25
27.3%
5.4%
Q4 24
16.4%
Q3 24
18.7%
10.9%
Q2 24
23.8%
-15.4%
Q1 24
27.1%
-34.7%
EPS (diluted)
CASH
CASH
IMCR
IMCR
Q4 25
$1.57
$-0.61
Q3 25
$1.69
$0.00
Q2 25
$1.81
$-0.20
Q1 25
$3.14
$0.10
Q4 24
$1.23
$-0.47
Q3 24
$1.34
$0.17
Q2 24
$1.78
$-0.23
Q1 24
$2.74
$-0.49

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CASH
CASH
IMCR
IMCR
Cash + ST InvestmentsLiquidity on hand
$331.2M
$864.2M
Total DebtLower is stronger
$33.5M
Stockholders' EquityBook value
$854.5M
$381.0M
Total Assets
$7.6B
$1.1B
Debt / EquityLower = less leverage
0.04×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CASH
CASH
IMCR
IMCR
Q4 25
$331.2M
$864.2M
Q3 25
$120.6M
$892.4M
Q2 25
$258.3M
$882.8M
Q1 25
$254.2M
$837.0M
Q4 24
$597.4M
$820.4M
Q3 24
$158.3M
$901.3M
Q2 24
$298.9M
$859.6M
Q1 24
$347.9M
$832.8M
Total Debt
CASH
CASH
IMCR
IMCR
Q4 25
$33.5M
Q3 25
$33.5M
Q2 25
$33.4M
Q1 25
$33.4M
Q4 24
$33.4M
Q3 24
$33.4M
$438.7M
Q2 24
$33.3M
$452.5M
Q1 24
$33.4M
$452.5M
Stockholders' Equity
CASH
CASH
IMCR
IMCR
Q4 25
$854.5M
$381.0M
Q3 25
$858.0M
$396.6M
Q2 25
$819.0M
$388.5M
Q1 25
$814.7M
$378.5M
Q4 24
$758.3M
$360.7M
Q3 24
$822.5M
$377.8M
Q2 24
$748.4M
$359.1M
Q1 24
$719.5M
$359.5M
Total Assets
CASH
CASH
IMCR
IMCR
Q4 25
$7.6B
$1.1B
Q3 25
$7.2B
$1.1B
Q2 25
$7.2B
$1.1B
Q1 25
$7.0B
$1.0B
Q4 24
$7.6B
$1.0B
Q3 24
$7.5B
$1.1B
Q2 24
$7.5B
$1.0B
Q1 24
$7.4B
$994.0M
Debt / Equity
CASH
CASH
IMCR
IMCR
Q4 25
0.04×
Q3 25
0.04×
Q2 25
0.04×
Q1 25
0.04×
Q4 24
0.04×
Q3 24
0.04×
1.16×
Q2 24
0.04×
1.26×
Q1 24
0.05×
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CASH
CASH
IMCR
IMCR
Operating Cash FlowLast quarter
$108.3M
$-32.7M
Free Cash FlowOCF − Capex
$104.1M
$-35.5M
FCF MarginFCF / Revenue
60.1%
-34.0%
Capex IntensityCapex / Revenue
2.4%
2.8%
Cash ConversionOCF / Net Profit
3.08×
TTM Free Cash FlowTrailing 4 quarters
$616.8M
$-15.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CASH
CASH
IMCR
IMCR
Q4 25
$108.3M
$-32.7M
Q3 25
$303.7M
$-4.5M
Q2 25
$30.4M
$26.0M
Q1 25
$188.3M
$435.0K
Q4 24
$-71.7M
$-14.0M
Q3 24
$143.1M
$21.1M
Q2 24
$113.2M
$23.5M
Q1 24
$203.0M
$-4.6M
Free Cash Flow
CASH
CASH
IMCR
IMCR
Q4 25
$104.1M
$-35.5M
Q3 25
$300.3M
$-5.2M
Q2 25
$27.7M
$25.6M
Q1 25
$184.7M
$137.0K
Q4 24
$-73.8M
$-17.5M
Q3 24
$138.8M
$20.3M
Q2 24
$111.0M
$23.1M
Q1 24
$201.3M
$-5.0M
FCF Margin
CASH
CASH
IMCR
IMCR
Q4 25
60.1%
-34.0%
Q3 25
160.9%
-5.0%
Q2 25
14.1%
26.1%
Q1 25
67.2%
0.1%
Q4 24
-40.4%
-20.9%
Q3 24
77.3%
25.3%
Q2 24
58.8%
30.7%
Q1 24
78.1%
-7.1%
Capex Intensity
CASH
CASH
IMCR
IMCR
Q4 25
2.4%
2.8%
Q3 25
1.8%
0.7%
Q2 25
1.4%
0.4%
Q1 25
1.3%
0.3%
Q4 24
1.1%
4.3%
Q3 24
2.4%
1.0%
Q2 24
1.2%
0.4%
Q1 24
0.7%
0.6%
Cash Conversion
CASH
CASH
IMCR
IMCR
Q4 25
3.08×
Q3 25
7.83×
Q2 25
0.72×
Q1 25
2.51×
0.09×
Q4 24
-2.39×
Q3 24
4.27×
2.42×
Q2 24
2.52×
Q1 24
2.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CASH
CASH

Consumer$103.0M59%
Payment Card And Deposit Fees$30.1M17%
Other$24.2M14%
Rental Income$11.6M7%
Commercial$4.2M2%

IMCR
IMCR

Segment breakdown not available.

Related Comparisons